Mannitol
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:Mannitol structure.png | |
| Mannitol
| |
| Systematic (IUPAC) name | |
| (2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol | |
| Identifiers | |
| CAS number | |
| ATC code | A06 B05BC01 B05CX04 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C6H14O6 |
| Mol. mass | 182.172 |
| Pharmacokinetic data | |
| Bioavailability | ~7% |
| Metabolism | Hepatic, negligible. |
| Half life | 100 minutes |
| Excretion | Renal: 90% |
| Therapeutic considerations | |
| Pregnancy cat. |
C: (USA) |
| Legal status |
? |
| Routes | Intravenous Oral |
|
WikiDoc Resources for Mannitol | |
|
Articles | |
|---|---|
|
Most recent articles on Mannitol | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Mannitol at Clinical Trials.gov Clinical Trials on Mannitol at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Mannitol
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Directions to Hospitals Treating Mannitol Risk calculators and risk factors for Mannitol
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Mannitol | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Mannitol or hexan-1,2,3,4,5,6-hexol (C6H8(OH)6) is an osmotic diuretic agent and a weak renal vasodilator. It is a sorbitol stereoisomer.
It was originally isolated from manna, and may also be referred to as Mannite and Manna Sugar.[1]
Chemical properties
Chemically, mannitol is a sugar alcohol, or a polyol; it is similar to xylitol or sorbitol. However, mannitol has a tendency to lose a hydrogen ion in aqueous solutions, which causes the solution to become acidic. For this, it is not uncommon to add a substance to adjust its pH, such as sodium bicarbonate.
Uses
Mannitol is used clinically to reduce acutely raised intracranial pressure, until more definitive treatment can be given, e.g. after head trauma (although significant controversy exists over this use), and to treat patients with oliguric renal failure. It is administered intravenously, and is filtered by the glomerulus of the kidney, but is incapable of being reabsorbed from the renal tubule, resulting in decreased water and Na+ reabsorption via its osmotic effect. Consequently, mannitol increases water and Na+ excretion, thereby decreasing extracellular fluid volume.
Mannitol fermentation can be used to distinguish species of bacteria from eachother. For this process, MSA Mannitol-Salt Agar could be used, thereby allowing both testing mannitol fermentation and tolerance to salt. In the MSA Agar, phenol red pH indicator turns yellow in the presence of acid by-products of mannitol fermentation. Staphylococcus aureus ferments mannitol. S. aureus changes the color of the medium from pink to yellow due to acid by-products of mannitol fermentation .Staphylococcus epidermidis grows on MSA, but does not ferment mannitol (media remains light pink in color & colonies are colorless.
Mannitol can also be used to open the blood-brain barrier by temporarily shrinking the tightly coupled endothelial cells that make up the barrier. This makes mannitol indispensable for delivering various drugs directly to the brain (e.g. in the treatment of Alzheimer's disease).
Mannitol is also used as a sweetener for people with diabetes. Since mannitol has a negative heat of solution, it is used as a sweetener in "breath-freshening" candies, the cooling effect adding to the fresh feel. In doses larger than 20g, mannitol acts as a laxative, and is sometimes sold as a laxative for children.
It is sometimes used as an adulterant or cutting agent for heroin, methamphetamines or other illicit drugs. In popular culture, when it is used in this manner, it is often referred to as baby laxative. Many television shows and films depicting drug culture make such references to baby laxative when in fact they are referring to Mannitol.
Mannitol can also be used to temporarily encapsulate a sharp object (such as a helix on a lead for an artificial pacemaker) while it is passing through the venous system. Because it dissolves readily in blood, the sharp point will become exposed by the time it reaches its destination.
Mannitol may be administered in cases of severe Ciguatera poisoning. Severe ciguatoxin, or "tropical fish poisoning" can produce stroke-like symptoms.
Mannitol is a non-permeating molecule i.e. it cannot cross biological membranes.
Mannitol is commonly used in the circuit prime of a heart lung machine during cardiopulmonary bypass (CPB). The presence of mannitol preserves renal function during the times of low blood flow and pressure, while the patient is on bypass. The solution prevents the swelling of endothelial cells in the kidney, which may have otherwise reduced blood flow to this area and resulted in cell damage.
Mannitol is also being developed by an Australian pharmaceutical company as a treatment for cystic fibrosis and bronchiectasis and as a diagnostic test for airway hyperresponsiveness. The mannitol is orally inhaled as a dry powder through what is known as an osmohaler. The critical component of the mannitol being the particle size distribution (PSD). The company has marketing approval for its diagnostic in Australia and Europe and is currently applying for approval from the FDA.
Chemical Abstract Registry Numbers for Mannitol are: 123897-58-5 69-65-8 75398-80-0 85085-15-0
Controversy
The three studies[1], [1], [1] which initially found that mannitol was effective in cases of severe head injury have been the subject of a recent investigation[1]. Although several authors are listed, the others had no knowledge of how, where, or even if the patients were recruited, meaning that the papers were essentially conducted by Dr. Cruz, who killed himself in 2005. Further, the Federal University of São Paulo, which he gave as his affiliation, has never employed him. Currently, therefore, the Cochrane review recommending mannitol[1] has been withdrawn pending re-evaluation, as there is some evidence that mannitol may worsen cerebral oedema[1].
References
External links
Use of Mannitol in Bacteria Differentiation-scroll down to MSA Agar
de:Mannitfr:Mannitolit:Mannitolo nl:Mannitol ja:マンニトールsv:Mannitol
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
